LFCR

Lifecore Biomedical Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Momentum↑ 5/10
Lifecore Biomedical sales and earnings growth
LFCR Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ 0.00%
Lifecore Biomedical gross and profit margin trends
LFCR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ 0.00%
Lifecore Biomedical net debt vs free cash flow
LFCR Risk
Poor
  • Debt / Equity↑ 3.7
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 0.0

Lifecore Biomedical stock volatility is higher than the overall market. We give it a Poor risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗